Prostate International

Papers
(The TQCC of Prostate International is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
A review of social determinants of prostate cancer risk, stage, and survival61
Prostate diseases and microbiome in the prostate, gut, and urine28
Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients’ survival and responses to androgen deprivation therapies in Indonesian patients cohort26
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer24
Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer19
Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia17
Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review17
Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies15
Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study14
Impact of surgically maximized versus native membranous urethral length on 30-day and long-term pad-free continence after robot-assisted radical prostatectomy14
Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients14
Changes in diagnosis rate and treatment trends of benign prostatic hyperplasia in Korea: A nationwide population-based cohort study13
What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?13
Open simple prostatectomy and robotic simple prostatectomy for large benign prostatic hyperplasia: Comparison of safety and efficacy12
Survival and quality of life outcomes of high-intensity focused ultrasound treatment of localized prostate cancer11
Impact of positive surgical margin on biochemical recurrence in localized prostate cancer11
A systematic review of outcomes after thermal and nonthermal partial prostate ablation11
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures10
Impact of the evolving United States Preventative Services Task Force policy statements on incidence and distribution of prostate cancer over 15 years in a statewide cancer registry10
Changing trends in robot-assisted radical prostatectomy: Inverse stage migration—A retrospective analysis10
Rebiopsy rate after transperineal or transrectal prostate biopsy10
Micro-Ultrasound: a way to bring imaging for prostate cancer back to urology9
Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group9
Robotic-assisted simple prostatectomy versus holmium laser enucleation of the prostate for large benign prostatic hyperplasia: A single-center preliminary study in Korea9
RNA-seq profile of African American men with a clinically localized prostate cancer8
Risk factors associated with pain in fusion prostate biopsy8
A study on prostate movement and dosimetric variation because of bladder and rectum volumes changes during the course of image-guided radiotherapy in prostate cancer8
Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer8
Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rect8
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship8
Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy7
Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride7
Minimal invasive management of bladder neck contracture using Allium round posterior stent: the long-term results7
The significance of the visible tumor on preoperative magnetic resonance imaging in localized prostate cancer7
Comparing open and robotic salvage radical prostatectomy after radiotherapy: predictors and outcomes7
Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description7
Measurement of autophagy flux in benign prostatic hyperplasia in vitro7
The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A prop6
Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer6
Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy6
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients6
Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?6
Factors affecting biochemical recurrence of prostate cancer after radical prostatectomy in patients with positive and negative surgical margin6
0.031978845596313